surmount-1 tirzepatide obesity nejm 2022 weight loss percent SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes Surmount Press Briefing #ADA2022

Pharmacists should also use their professional judgement to assess the patient is competent to administer the medicine by: asking open-ended questions, such as, can you tell me the steps you will take to self-administer the medicine? confirming the patients knowledge, including the size of the dose, and vial size watching the patient administer their first dose

Comparison decision path Use this comparison to narrow the provider review question Direct answer Mochi Health vs Ro for GLP-1: Two Rising Telehealth Platforms should help you decide which option deserves a clinical review, not force a one-size answer

Liquid calories from protein shakes, smoothies with added fats, and calorie-dense recovery meals become essential

Patients should never discontinue tirzepatide or adjust their dose without consulting their healthcare provider, as abrupt changes in diabetes management can lead to adverse outcomes

Drink water, clear broths, diluted sports drinks, or oral rehydration solutions to replace fluid and electrolyte losses

Do Patients Regain Weight After Stopping Treatment